SAM
CLB icon

Silvercrest Asset Management’s Core Laboratories CLB Stock Holding History

Silvercrest Asset Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,130
Closed -$233K – 563
2017
Q4 		$233K Buy
+2,130
New +$213K ﹤0.01% 519

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Silvercrest Asset Management's CLB Position: Q1 2018 in Review

Silvercrest Asset Management sold out of Core Laboratories (CLB) in Q1 2018, closing a stake of 2,130 shares — an estimated $233K sold.

Silvercrest Asset Management first reported a position in CLB in Q4 2017 and held it in 1 quarter. The position peaked at $233K in Q4 2017. 355 funds tracked by Wall St. Rank hold CLB as of Q1 2018.

  • Silvercrest Asset Management reported no remaining Core Laboratories position as of Q1 2018 after selling out during the quarter.
  • Silvercrest Asset Management sold 2,130 Core Laboratories shares in Q1 2018, an estimated $233K.
  • Silvercrest Asset Management first reported a position in Core Laboratories in Q4 2017 and held it in 1 quarter.
  • Silvercrest Asset Management's Core Laboratories position peaked at $233K in Q4 2017.
  • 355 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2018.

Based on Silvercrest Asset Management's 13F filing for Q1 2018, filed 15 May 2018.